Historical record - last NADAC effective date: 4/21/2021
Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Epic Pharma LLC, priced at $0.0657 per EA under NDC 42806051110. Its NADAC has been published 160 times since Apr 11, 2018.
FDA first approved this application on Mar 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Epic Pharma LLCNDC
42806051110
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/21/2021
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207099FDA Approved
3/24/2017
TE Code
AB
On Market Since
3/24/2017
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 160 times since Apr 11, 2018, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0657 per EA |
|---|---|
| All-time high | $0.0789 (Jan 16, 2019) |
| All-time low | $0.0595 (Jun 20, 2018) |
| Median price | $0.0685 |
| Average price | $0.0687 |
| Largest weekly change | +22.5% (Jul 18, 2018) |
| Weeks tracked | 160 |
| Tracking since | Apr 11, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-2.3%
Last surveyed Apr 28, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Epic Pharma LLC, is $0.0657 per EA (NDC 42806051110), effective Apr 28, 2021.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 2.3%. It has been tracked across 160 weekly CMS publications since Apr 11, 2018.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Apr 11, 2018, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0595 (Jun 20, 2018) to a high of $0.0789 (Jan 16, 2019), with a median of $0.0685 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 400 MG CAPSULE, is $0.0400 per EA — about 39% below GABAPENTIN 400 MG CAPSULE.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 42806051110) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.